dpp-4 inhibitor and glp-1 receptor agonist combination dpp-4_inhibitors [TUSOM GLP-1 receptor agonists and DPP-4

For people without significant medical problems who are not taking interacting medications, a cautious trial at low dose is reasonable when benefits are expected

Adds antioxidant support and pairs well with glutathione

[3] While CVS often begins in childhood, many adults continue to experience episodes, even with treatment to lessen their severity and frequency

doi: 10.3390/nu12082178 Summary Keywords insulin resistance, L-carnitine, lipid metabolism, MASLD, mitochondrial function Citation Chen C, Zou J, Li L, Liu S, Liu Z, Yao L, Peng P, Liang J, Chen Z, Huang H and Huang J (2026) Lcarnitine in metabolic dysfunction-associated steatotic liver disease: mechanisms and therapeutic potential

doi: 10.3389/fendo.2025.1568059 Received 28 January 2025 Accepted 10 April 2025 Published 30 April 2025 Volume 16 - 2025 Edited by Joao Dts Anselmo, Hospital do Divino Esprito Santo, Portugal Reviewed by Lucile Butruille, Musum National dHistoire Naturelle, France Updates Copyright 2025 Khudair, Khudair, Niinuma, Habib and Butler